NCT01216033已完成1 期
An Exploratory Study to Evaluate the Distribution of [111In]ABY-025 Uptake for SPECT Imaging in Subjects With Metastatic Breast Cancer
Biomedical Radiation Sciences2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2010年10月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 7
- 试验地点
- 2
- 主要终点
- Imaging of metastases
研究概览
简要总结
The aim is to study if breast cancer metastases accumulate the newly developed HER2 binding molecule 111-In-ABY025 and if that shows whether the metastases express HER2.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •female age >20 years
- •one or more known metastases localizations
排除标准
- •other critical disease than breast cancer
- •age ≤ 20 years
结局指标
主要结局
Imaging of metastases
时间窗: One year
Imaging of breast cancer metastases using 111-In-ABY015 for SPECT
次要结局
- Can the new molecule be used for imaging in extended studies(October 2010 - June 2011)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
2 期
Basket Study for Oligo-metastatic Breast CancerHER2-positive Breast CancerNCT05982678The Netherlands Cancer Institute72
已完成
1 期
A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901HER2+ CancerNCT01526473H. Kim Lyerly22
已完成
2 期
Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast CancerMetastatic Breast CancerNCT00976365Taiwan THL Co.LTd.60
已完成
1 期
Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic CancerMetastatic Colorectal CancerMetastatic Pancreatic CancerNCT03168139TME Pharma AG20
已完成
2 期
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast CancerBreast CancerNCT00721630Memorial Sloan Kettering Cancer Center24